Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Alkermes Plc (ALKS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,699,334
  • Shares Outstanding, K 153,780
  • Annual Sales, $ 745,690 K
  • Annual Income, $ -208,440 K
  • 36-Month Beta 2.13
  • Price/Sales 10.28
  • Price/Cash Flow N/A
  • Price/Book 7.60

Price Performance

See More
Period Period Low Period High Performance
1-Month
51.71 +9.40%
on 12/20/17
60.50 -6.50%
on 01/11/18
+3.95 (+7.51%)
since 12/15/17
3-Month
46.42 +21.85%
on 11/15/17
60.50 -6.50%
on 01/11/18
+5.82 (+11.47%)
since 10/16/17
52-Week
46.42 +21.85%
on 11/15/17
63.40 -10.77%
on 06/09/17
+1.11 (+2.00%)
since 01/13/17

Most Recent Stories

More News
3 Biotech Stocks Start Healthy in '18: Will the Rally Last?

We take a look at some biotech stocks that have witnessed an increase in their share price this year so far and look well positioned for the rest of 2018.

AGEN : 3.79 (-2.07%)
MRK : 62.07 (+5.81%)
VRTX : 155.71 (-1.41%)
NVS : 86.73 (+0.09%)
ALKS : 56.57 (-3.65%)
GSK : 37.92 (+1.12%)
ALKS UPCOMING DEADLINE: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Alkermes plc and a Lead Plaintiff Deadline of January 22, 2018

NEW YORK, NY / ACCESSWIRE / January 16, 2018 / The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Southern District of New...

ALKS : 56.57 (-3.65%)
DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Alkermes plc (ALKS) & Lead Plaintiff Deadline- January 22, 2018

NEW YORK, NY / ACCESSWIRE / January 16, 2018 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Alkermes plc ("Alkermes" or the "Company") (NASDAQ:...

ALKS : 56.57 (-3.65%)
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Alkermes plc of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 22, 2018 - ALKS

NEW YORK, NY / ACCESSWIRE / January 15, 2018 / The following statement is being issued by Levi & Korsinsky, LLP:

ALKS : 56.57 (-3.65%)
3 Pharma and Biotech Stocks to Watch Out for in 2018

Here is a look at three pharma and biotech stocks including Alkermes (ALKS) that look well-positioned for 2018.

XOMA : 31.56 (-6.38%)
NVS : 86.73 (+0.09%)
ALKS : 56.57 (-3.65%)
BIIB : 338.85 (+0.86%)
EIGR : 8.10 (-49.37%)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Alkermes plc of Class Action Lawsuit and Upcoming Deadline - ALKS

NEW YORK, NY / ACCESSWIRE / January 13, 2018 / Pomerantz LLP announces that a class action lawsuit has been filed against Alkermes plc ("Alkermes" or the "Company") (NASDAQ: ALKS) and certain of its officers....

ALKS : 56.57 (-3.65%)
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Alkermes plc of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 22, 2018 - ALKS

NEW YORK, NY / ACCESSWIRE / January 10, 2018 / The following statement is being issued by Levi & Korsinsky, LLP:

ALKS : 56.57 (-3.65%)
ALKERMES INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Alkermes plc To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Alkermes plc ("Alkermes" or the "Company") (NASDAQ:ALKS) of the January 22, 2018 deadline to seek the role...

ALKS : 56.57 (-3.65%)
ALKS INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Alkermes plc and a Lead Plaintiff Deadline of January 22, 2018

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased Alkermes...

ALKS : 56.57 (-3.65%)
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Alkermes plc (ALKS) & Lead Plaintiff Deadline- January 22, 2018

NEW YORK, NY / ACCESSWIRE / January 9, 2018 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Alkermes plc ("Alkermes" or the "Company") (NASDAQ:...

ALKS : 56.57 (-3.65%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Alkermes, Inc. is a biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease. Alkermes currently has two commercial products: RISPERDAL CONSTA, the first and only long-acting atypical antipsychotic medication...

See More

Key Turning Points

2nd Resistance Point 59.97
1st Resistance Point 58.27
Last Price 56.57
1st Support Level 55.65
2nd Support Level 54.73

See More

52-Week High 63.40
Fibonacci 61.8% 56.92
Last Price 56.57
Fibonacci 50% 54.91
Fibonacci 38.2% 52.91
52-Week Low 46.42

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.